Oncolytics Biotech CEO, Thompson while taking forward the CBS’60 Minutes report on cancer treatments that are vrisu-based, said that there were many more angles to be considered with the treatment. In a report published in Forbes recently, it was explained that the show was focused on the engineered polio virus which was created at the Duke University in order to treat a fatal kind of brain cancer, glioblastoma.
Thompson said that he is not just aware about such treatments, but also understands the complexity of bringing them into the market. Oncolytics Biotech, which was formed in 1998, explains a range of discoveries that have been done at the University of Calgary. These discoveries focus on the reovirus...
Also read: Huntsman, Clariant Near Deal to Merge